JPRN-UMIN000015159已完成未知
Effects of Fabry disease on the prognosis of cerebrovascular disease - Effects of Fabry disease on the prognosis of cerebrovascular disease
Yokohama Stroke and Brain Center0 个研究点目标入组 200 人开始时间: 2014年9月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 15years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Prevalence of Fabry disease in patients with cerevrovascular disease.Cerevrovascular diseaseJPRN-UMIN000015160Yokohama Stroke and Brain Ccenter200
撤回
不适用
Evaluation of Phenotypic Variability in Fabry DiseaseFabry DiseaseNCT03145779Boston Children's Hospital
已完成
4 期
A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry DiseaseFabry DiseaseNCT00074984Genzyme, a Sanofi Company82
已完成
不适用
The epidemiologic research of Fabry disease for hypertrophic cardiomyopathy in Yokohama.Fabry diseaseJPRN-UMIN000015593Yokohama City University Hospital480
已完成
不适用
Prevalence of Fabry disease among patients with hypertrophic cardiomyopathy, dilated cardiomyopathy and left ventricular hypertrophy with proteinuriaFabry diseaseJPRN-UMIN000015821Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine500